KR970706840A - 성장호르몬 및 발린으로 이루어진 약학적 조성물(a pharmaceutical formulation comprising a growth hormone and valine) - Google Patents

성장호르몬 및 발린으로 이루어진 약학적 조성물(a pharmaceutical formulation comprising a growth hormone and valine)

Info

Publication number
KR970706840A
KR970706840A KR1019970702431A KR19970702431A KR970706840A KR 970706840 A KR970706840 A KR 970706840A KR 1019970702431 A KR1019970702431 A KR 1019970702431A KR 19970702431 A KR19970702431 A KR 19970702431A KR 970706840 A KR970706840 A KR 970706840A
Authority
KR
South Korea
Prior art keywords
valine
growth hormone
pharmaceutical formulation
dissolved
formulation
Prior art date
Application number
KR1019970702431A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR970706840A publication Critical patent/KR970706840A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019970702431A 1994-10-13 1997-04-14 성장호르몬 및 발린으로 이루어진 약학적 조성물(a pharmaceutical formulation comprising a growth hormone and valine) KR970706840A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/322,260 US5547696A (en) 1994-10-13 1994-10-13 Pharmaceutical formulation
PCT/DK1995/000408 WO1996011702A1 (en) 1994-10-13 1995-10-13 A pharmaceutical formulation comprising a growth hormone and valine

Publications (1)

Publication Number Publication Date
KR970706840A true KR970706840A (ko) 1997-12-01

Family

ID=23254095

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970702431A KR970706840A (ko) 1994-10-13 1997-04-14 성장호르몬 및 발린으로 이루어진 약학적 조성물(a pharmaceutical formulation comprising a growth hormone and valine)

Country Status (12)

Country Link
US (1) US5547696A (ko)
EP (1) EP0785795B1 (ko)
JP (1) JP4064453B2 (ko)
KR (1) KR970706840A (ko)
AT (1) ATE211653T1 (ko)
AU (1) AU699346B2 (ko)
DE (1) DE69524965T2 (ko)
ES (1) ES2171555T3 (ko)
IL (1) IL115591A (ko)
PT (1) PT785795E (ko)
WO (1) WO1996011702A1 (ko)
ZA (1) ZA958605B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK204791D0 (da) * 1991-12-20 1991-12-20 Novo Nordisk As Hidtil ukendt farmaceutisk praeparat
US6022858A (en) * 1991-12-20 2000-02-08 Novo Nordisk A/S Pharmaceutical formulation of human-growth hormone pretreated with zinc salt
US6673335B1 (en) 1992-07-08 2004-01-06 Nektar Therapeutics Compositions and methods for the pulmonary delivery of aerosolized medicaments
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US6290991B1 (en) * 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US20070179096A1 (en) 1996-04-24 2007-08-02 Novo Nordisk A/S Pharmaceutical Formulation
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
DK1280520T4 (en) 2000-05-10 2018-06-25 Novartis Ag Phospholipid based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CA2418960A1 (en) 2000-08-07 2002-02-14 Inhale Therapeutic Systems, Inc. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
EP1458360B1 (en) 2001-12-19 2011-05-11 Novartis AG Pulmonary delivery of aminoglycosides
US7951368B2 (en) * 2007-06-25 2011-05-31 Amgen Inc. Compositions of specific binding agents to hepatocyte growth factor

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
DE3228502A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung des c1-inaktivators und seine verwendung
JPS5967228A (ja) * 1982-10-07 1984-04-16 Green Cross Corp:The 寒冷不溶性グロブリンの凍結乾燥方法
SU1232681A1 (ru) * 1984-11-20 1986-05-23 Научно-Исследовательский Технологический Институт Аминокислот Штамм @ @ СН-1-продуцент @ -валина
US4917685A (en) * 1986-05-16 1990-04-17 International Minerals & Chem. Corp. Delivery device for the administration of stabilized growth promoting hormones
US5041378A (en) * 1987-08-11 1991-08-20 Cetus Corporation Procaryotic xylose isomerase muteins
ES2044941T5 (es) * 1987-08-21 1999-02-16 Mallinckrodt Group Inc Estabilizador de hormonas promotoras del crecimiento.
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
EP0374120A3 (en) * 1988-12-13 1991-07-31 Monsanto Company Comosition for controlled release of polypeptides
DE69232847T2 (de) * 1991-12-20 2003-09-11 Novo Nordisk As Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
DK204791D0 (da) * 1991-12-20 1991-12-20 Novo Nordisk As Hidtil ukendt farmaceutisk praeparat
SE9201073D0 (sv) * 1992-04-03 1992-04-03 Kabi Pharmacia Ab Protein formulation
AU686567C (en) * 1992-07-31 2002-08-08 Genentech Inc. Human growth hormone aqueous formulation

Also Published As

Publication number Publication date
US5547696A (en) 1996-08-20
JP4064453B2 (ja) 2008-03-19
JPH10507181A (ja) 1998-07-14
EP0785795A1 (en) 1997-07-30
AU699346B2 (en) 1998-12-03
IL115591A0 (en) 1996-01-19
AU3605295A (en) 1996-05-06
DE69524965D1 (de) 2002-02-14
ES2171555T3 (es) 2002-09-16
PT785795E (pt) 2002-07-31
IL115591A (en) 2000-01-31
DE69524965T2 (de) 2002-08-14
WO1996011702A1 (en) 1996-04-25
ZA958605B (en) 1996-05-14
ATE211653T1 (de) 2002-01-15
EP0785795B1 (en) 2002-01-09

Similar Documents

Publication Publication Date Title
DK204791D0 (da) Hidtil ukendt farmaceutisk praeparat
IL115590A0 (en) Pharmaceutical formulation comprising a growth hormone and isoleucine
KR970706840A (ko) 성장호르몬 및 발린으로 이루어진 약학적 조성물(a pharmaceutical formulation comprising a growth hormone and valine)
AU610636B2 (en) Stabilised human protein preparations
ES2185625T3 (es) Formulacion farmaceutica estabilizada que incluye hormona de crecimiento e histidina.
PT1123120E (pt) Formulacao medicinal em aerossol
BG106046A (en) Pharmaceutical compositions of ertythropoietin
ES2172594T3 (es) Una formulacion farmaceutica que comprende una hormona de crecimiento y leucina.
NO980103L (no) Stabilisert farmasöytisk preparat som omfatter et veksthormon og et peptid omfattende minst én basisk aminosyrerest og minst én sur aminosyrerest
MX9800358A (es) Formulacion farmaceutica estabilizada que comprende una hormona del crecimiento pretratada con zinc y opcionalmente lisina o iones calcio.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee